|
Background:
Chloroquine and hydroxychloroquine belong to the
quinolone family. They are related drugs with different therapeutic and toxic
doses with similar clinical indications for use and manifestations of retinal
toxicity.
Initially, chloroquine was given for malaria prophylaxis and treatment, and,
later, it was used by rheumatologists for treating rheumatoid arthritis,
systemic/discoid lupus erythematosus, and other connective tissue disorders.
Dermatologists use these drugs for cutaneous lupus. Since it is far less toxic
to the retina, hydroxychloroquine has replaced chloroquine, except for
individuals who travel in areas endemic with malaria.
Expanded use of these drugs for nonmalarial disease entities has resulted in
prolonged duration of therapy and higher daily dosages leading to cumulative
doses greater than those used in antimalarial therapy. The first reports of
retinal toxicity attributed to chloroquine appeared during the late 1950s. In
1958, Cambiaggi first described the classic retinal pigment changes in a patient
receiving chloroquine for systemic lupus erythematous (SLE) treatment. In 1959,
Hobbs established a definite link between long-term use of chloroquine and
subsequent development of retinal pathology. In 1962, J Lawton Smith coined the
term bull's eye maculopathy, regarded as the classic finding of macular
toxicity. Many reports on chloroquine retinopathy exist. In contrast, only a few
cases of hydroxychloroquine toxicity have been reported.
Pathophysiology:
Chloroquine has an affinity for pigmented
(melanin-containing) structures, which may explain its toxic properties in the
eye. Melanin serves as a free-radical stabilizer and as an agent that can bind
toxins. Although it binds potentially retinotoxic drugs, it is unclear whether
the effect is beneficial or harmful. Chloroquine and its principal metabolite
have been found in the pigmented ocular structures at concentrations much
greater than in any other tissue in the body. With more prolonged exposure, the
drug accumulates in the retina. The drug is retained in the pigmented structures
long after its use is stopped. The kinetics of chloroquine metabolism are
complicated, with the half-life increasing as the dosage is increased. In
patients with retinopathy, 5 years or more after discontinuation, traces of
chloroquine have been found in plasma, erythrocytes, and urine.
Frequency:
-
In the US:
Two trends are consistent in literature,
despite the variability of the statistics; the incidence of retinopathy
increased with both the dose and the duration of treatment.
Bernstein estimated an incidence of 10% in unmonitored patients taking 250
mg/d of chloroquine and 3-4% in unmonitored patients taking 400 mg/d of
hydroxychloroquine.
Mortality/Morbidity:
See Clinical
for detailed information.
Race: No known racial predilection exists.
Sex: No known sexual predilection exists.
Age: No known age predisposition exists.
How do I get more information?
There are several ways of reaching the ophthalmologists of EYE REPUBLIC Ophthalmology Clinic:
Hover note: Please place your mouse cursor over the red box
to click on the web and email links. For websites, a new browser
window will open. For emails, your default email program will
open. You may cut and paste the URLs or email addresses if you
prefer not to open new windows.
ONLINE ACCESS
WEBSITES.
http://www.EyeRepublic.com.ph - EYE REPUBLIC
Ophthalmology Clinic
http://www.OCP.com.ph - Ophthalmic
Consultants Philippines Co. -
http://www.LASIK.com.ph - Refractive
Surgery Resource
http://www.Cataract.com.ph - Cataract Surgery Resource
http://www.Eye.com.ph - Eye
Information Online
http://www.EyeDoc4Kids.com.ph - Eye Information for Kids
http://www.Retina.com.ph - Retina
Surgery Resource
http://www.Glaucoma.com.ph - Glaucoma
Online
http://www.Uveitis.com.ph - Uveitis Online
EMAIL. After writing down your comments,
suggestions, problems and/or questions, kindly tell us how
to get in touch with you by providing your name, email,
home/office numbers, and mobile phone.
General inquiries - help@EyeRepublic.com.ph
Refractive Surgery Service - refractive.surgery@EyeRepublic.com.ph
Glaucoma Service - glaucoma@EyeRepublic.com.ph
Cataract Service - cataract@EyeRepublic.com.ph
Doctors - eyemd@EyeRepublic.com.ph
Administrative - president@EyeRepublic.com.ph
Website - webmaster@EyeRepublic.com.ph
Newsletter -
newsletter@EyeRepublic.com.ph (receive
news and updates, discounts and promotions)
BLOG. Send us your comments.
EYE REPUBLIC
Ophthalmology Atlas
CLINIC INFORMATION
Mobile E-Yellow Pages. Via
SMS, text LUK4 EYEREPUBLIC
(send to 2851 for Globe and Sun Cellular, and 2951 for Smart). |
EYE REPUBLIC Ophthalmology Clinic
Manila
3/F Don Santiago Building Units 309-310
1344 Taft Avenue, Ermita
Manila, 1000 Philippines
Direct and Fax: (632) 536-2398
Trunk Line: (632) 523-8271 to 79 local 30
Mobile: (63917) 899-2020
Map and directions
|
EYE REPUBLIC
Ophthalmology Clinic
Asian Hospital
and Medical Center
5/F Medical Office
Building (MOB) Suite 509
2205 Civic Drive,
Filinvest, Alabang
Muntinlupa City,
1781 Philippines
Direct:
(632) 771-9253
Direct and Fax:
(632) 771-9254
Mobile: (63917) 795-2020
Map and Directions
|
EYE REPUBLIC Ophthalmology Clinic
Medical City
6/F Medical Arts Tower Inc (MATI) Suite 602
MERALCO Compound, Ortigas Avenue
Pasig City, 1604, Philippines
Direct and Fax: (632) 632-7846
Mobile: (63917) 537-2020
Map and directions
|
EYE REPUBLIC
Ophthalmology Clinic
St. Luke's
Medical Center
6/F
Cathedral Heights Building Complex (CHBC)
North Tower Suite 614
279 E. Rodriguez
Sr. Boulevard
Quezon City, 1102
Philippines
Direct and Fax:
(632) 407-3883
Mobile: (63917) 855-2020
Map and directions
|
CLINIC HOURS
First-Come, First-Served
Monday to Saturday 9:00 AM to 6:00 PM
All clinics are closed on Sundays and Holidays
|
|
Back to Top
CHLOROQUINE TOXICITY information
compiled by Dr.
Manolette R. Roque and initially uploaded on May 1, 2005.
Last updated on
September 13, 2007. |